Fatma A.F. Ragab

742 total citations
17 papers, 640 citations indexed

About

Fatma A.F. Ragab is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Fatma A.F. Ragab has authored 17 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 8 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Fatma A.F. Ragab's work include Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (4 papers) and Cancer Mechanisms and Therapy (3 papers). Fatma A.F. Ragab is often cited by papers focused on Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (4 papers) and Cancer Mechanisms and Therapy (3 papers). Fatma A.F. Ragab collaborates with scholars based in Egypt, United States and India. Fatma A.F. Ragab's co-authors include Hoda I. El Diwani, Heba T. Abdel‐Mohsen, Mamdouh M. Ali, Mostafa M. Ramla, Salah A. Abdel‐Aziz, Shadia A. Galal, Ahmed M. El Kerdawy, Sahar M. Abou‐Seri, Gerhard Wolber and Jérémie Mortier and has published in prestigious journals such as Molecules, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Fatma A.F. Ragab

17 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatma A.F. Ragab Egypt 11 513 216 77 55 46 17 640
Hanan M. Refaat Egypt 14 590 1.2× 173 0.8× 69 0.9× 39 0.7× 61 1.3× 22 704
Khalid B. Selim Egypt 17 773 1.5× 192 0.9× 60 0.8× 25 0.5× 36 0.8× 42 876
Sally I. Eissa Egypt 11 458 0.9× 250 1.2× 77 1.0× 75 1.4× 50 1.1× 16 602
Kishna Ram Senwar India 15 803 1.6× 359 1.7× 59 0.8× 61 1.1× 37 0.8× 17 958
Ahsan Ahmed Khan India 8 639 1.2× 219 1.0× 92 1.2× 44 0.8× 76 1.7× 9 771
Filippo Prencipe Italy 15 396 0.8× 164 0.8× 71 0.9× 29 0.5× 29 0.6× 28 544
Sravani Sana India 14 562 1.1× 255 1.2× 57 0.7× 38 0.7× 27 0.6× 18 668
María Kimatrai Salvador Italy 18 686 1.3× 251 1.2× 87 1.1× 46 0.8× 53 1.2× 23 815
Zainab M. Elsayed Egypt 16 488 1.0× 386 1.8× 83 1.1× 39 0.7× 58 1.3× 33 645
Zulphikar Ali India 9 657 1.3× 241 1.1× 99 1.3× 51 0.9× 78 1.7× 12 802

Countries citing papers authored by Fatma A.F. Ragab

Since Specialization
Citations

This map shows the geographic impact of Fatma A.F. Ragab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatma A.F. Ragab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatma A.F. Ragab more than expected).

Fields of papers citing papers by Fatma A.F. Ragab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatma A.F. Ragab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatma A.F. Ragab. The network helps show where Fatma A.F. Ragab may publish in the future.

Co-authorship network of co-authors of Fatma A.F. Ragab

This figure shows the co-authorship network connecting the top 25 collaborators of Fatma A.F. Ragab. A scholar is included among the top collaborators of Fatma A.F. Ragab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatma A.F. Ragab. Fatma A.F. Ragab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mohamed, Shaaban K., Youness El Bakri, S. Karthikeyan, et al.. (2023). Insights into the crystal structure and computational studies of newly synthesized thiazolopyrimidine derivatives against adenosine receptor (Thermostabilised HUMAN A2a). Journal of Molecular Structure. 1284. 135372–135372. 2 indexed citations
2.
Allam, Heba Abdelrasheed, et al.. (2023). Design and synthesis of certain 7-Aryl-2-Methyl-3-Substituted Pyrazolo{1,5-a}Pyrimidines as multikinase inhibitors. European Journal of Medicinal Chemistry. 262. 115918–115918. 12 indexed citations
3.
Mohamed, Shaaban K., et al.. (2022). Crystal structure and Hirshfeld surface analysis of ethyl (3E)-5-(4-fluorophenyl)3-{[(4-methoxyphenyl)formamido]imino}-7-methyl-2H,3H,5H-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylate 0.25-hydrate. Acta Crystallographica Section E Crystallographic Communications. 78(9). 880–884. 2 indexed citations
4.
Galal, Shadia A., Mohamed A. Omar, Fatma A.F. Ragab, et al.. (2021). Design and synthesis of new pyrazolylbenzimidazoles as sphingosine kinase-1 inhibitors. Medicinal Chemistry Research. 30(9). 1614–1634. 7 indexed citations
5.
Omar, Mohamed A., Fatma A.F. Ragab, Sonam Roy, et al.. (2021). Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor. Archiv der Pharmazie. 354(9). e2100080–e2100080. 9 indexed citations
6.
Abdel‐Aziz, Salah A., Adel A. Marzouk, Montaser Sh. A. Shaykoon, et al.. (2020). Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: Anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies. Bioorganic Chemistry. 108. 104555–104555. 46 indexed citations
7.
Abdel‐Mohsen, Heba T., Ahmed M. El Kerdawy, Fatma A.F. Ragab, et al.. (2020). Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles. Molecules. 25(4). 770–770. 51 indexed citations
9.
Ragab, Fatma A.F., et al.. (2017). Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moiety. European Journal of Medicinal Chemistry. 138. 140–151. 61 indexed citations
10.
Abdel‐Mohsen, Heba T., Ahmed M. El Kerdawy, Fatma A.F. Ragab, et al.. (2017). Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. European Journal of Medicinal Chemistry. 136. 315–329. 104 indexed citations
11.
Galal, Shadia A., et al.. (2016). Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5423–5430. 6 indexed citations
12.
El‐All, Amira S. Abd, Fatma A.F. Ragab, Mahmoud ElHefnawi, et al.. (2015). New Benzimidazoles and Their Antitumor Effects with Aurora A Kinase and KSP Inhibitory Activities. Archiv der Pharmazie. 348(7). 475–486. 22 indexed citations
13.
Galal, Shadia A., Fatma A.F. Ragab, Ahmed S. Abdelsamie, et al.. (2014). Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity. European Journal of Medicinal Chemistry. 86. 122–132. 121 indexed citations
14.
Shaker, Yasser M., Fatma A.F. Ragab, Mamdouh M. Ali, et al.. (2014). Synthesis, Biological Evaluation, and Docking Studies of New 2‐Furylbenzimidazoles as Anti‐Angiogenic Agents: Part II. Archiv der Pharmazie. 347(4). 291–304. 17 indexed citations
15.
Shaker, Yasser M., et al.. (2014). Part I. Synthesis, biological evaluation and docking studies of new 2-furylbenzimidazoles as antiangiogenic agents. European Journal of Medicinal Chemistry. 87. 868–880. 35 indexed citations
16.
Khattab, Muhammad, Shadia A. Galal, Fatma A.F. Ragab, & Hoda I. El Diwani. (2012). Different synthetic routes to 4-(1H-benzo[d]imidazol-2-yl)aniline. Research on Chemical Intermediates. 39(7). 2917–2923. 10 indexed citations
17.
Abdel‐Mohsen, Heba T., Fatma A.F. Ragab, Mostafa M. Ramla, & Hoda I. El Diwani. (2010). Novel benzimidazole–pyrimidine conjugates as potent antitumor agents. European Journal of Medicinal Chemistry. 45(6). 2336–2344. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026